Gamida Cell's cell therapy Omisirge receives FDA approval
The US Food and Drug Administration (FDA) has approved Gamida Cell’s allogeneic cell therapy, Omisirge (omidubicel-onlv), for blood cancer patients.
Archives for April 18, 2023
Dyadic licensing deal seeks affordable vaccines and biologics for Africa
Dyadic extends its licensing agreement with Rubic for the use of its C1-cell protein expression platform.
Genmab expands immunology reach in argenx pact
In a move to increase its presence in immunology and inflammation, the Danish biotech Genmab has launched a collaboration with argenx in the Netherlands to co-discover and co-develop antibody treatments.